1. Home >
  2. M&A >
  3. Buyout (LBO, MBO, MBI) >
  4. Switzerland >
  5. Gyrus Capital Acquires dss+

M&A Deal Summary

Gyrus Capital Acquires dss+

On February 25, 2019, private equity firm Gyrus Capital acquired business services company dss+

Acquisition Highlights
  • This is Gyrus Capital’s 1st transaction in the Business Services sector.
  • This is Gyrus Capital’s 1st transaction in Switzerland.
Investment Fate
  • dss+ was sold to a consortium of financial buyers in 2023.

M&A Deal Summary
Date 2019-02-25
Target dss+
Sector Business Services
Buyer(s) Gyrus Capital
Deal Type Buyout (LBO, MBO, MBI)

Target

dss+

Geneva, Switzerland
dss+ is a provider of operations management consulting services that enable organizations to protect their employees and assets, realize operational efficiencies, innovate more rapidly, and build workforce capability. By leveraging its DuPont heritage, deep industry and business process expertise, and diverse team of expert consultants, it helps clients turn operations management into a competitive advantage. dss+ was formed in 1968 and is based in Geneva, Switzerland.

Search 215,058 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Gyrus Capital

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2018
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

Gyrus Capital is a private equity firm focused on investments in established small and medium-sized businesses across Europe and North America. The Firm seeks to partner with management teams in companies operating in the healthcare, wellness, and sustainability oriented sectors. The Firm will support a variety of transaction situations, including buyouts, growth capital financings, divestitures, and consolidations. Specific industries of interest include pharmaceuticals, medical devices, food and nutrition, sanitation, renewable materials, and environmental services. Gyrus Capital was founded in 2018 and is based in Geneva, Switzerland.

DEAL STATS #
Overall 1 of 9
Sector: Business Services M&A 1 of 5
Type: Buyout (LBO, MBO, MBI) M&A Deals 1 of 5
Country: Switzerland M&A 1 of 3
Year: 2019 M&A 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-01-30 Essential Pharma

Egham, United Kingdom

Essential Pharma is a specialty generic pharma business focussed on CNS and other niche pharmaceutical products. Essential addresses the problem of drug shortages by ensuring the continued supply of low volume and legacy drugs with high clinical importance which are at risk of discontinuation and stockouts. Essential Pharma was established in 2011 and is based in Egham, United Kingdom.

Buy -
Mergr

Solution for

Product

Company

Legal